SCHEMBL342839

SCHEMBL342839

CCOc1ccc([NH])c(S(=O)(=O)O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTDSP1 Q9GZU7 1/20 0.49
ALDH1A1 P00352 4/20 0.44
CYP1A2 P05177 1/20 0.44
TSHR P16473 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
NQO1 P15559 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ESR2 Q92731 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PARP10 Q53GL7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL158763 0.81 L3MBTL1 (0.45) CYP1A2CA1CA2L3MBTL1MAPT
SCHEMBL342840 0.80 CTDSP1 (0.72) CTDSP1ALDH1A1CYP1A2TSHRCA12
SCHEMBL17924007 0.79 SMN1; SMN2 (0.58) CTDSP1ALDH1A1TSHRL3MBTL1MAPT
SCHEMBL1606269 0.77 CTDSP1 (0.59) CTDSP1ALDH1A1CYP1A2TSHRCA12
SCHEMBL7759862 0.75 HSD17B10 (0.41) CTDSP1ALDH1A1TSHRCA12CA1
SCHEMBL28751069 0.73 CTDSP1 (0.49) CTDSP1ALDH1A1CYP1A2TSHRCA12
SCHEMBL2332244 0.72 KDM4E (0.58) ALDH1A1CYP1A2TSHRCA12CA1
SCHEMBL10296073 0.72 MTNR1A (0.54) CTDSP1L3MBTL1GAAMAPK1TDP1
SCHEMBL27621617 0.71 MAPK1 (0.63) ALDH1A1CYP1A2L3MBTL1KDM4EGAA
SCHEMBL15801047 0.71 KDM4E (0.61) ALDH1A1CYP1A2TSHRCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10190009-B2 Ink composition, ink jet recording method using same, and colored material NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2019-01-29 US disclosed
EP-2441806-B1 PORPHYRAZINE COLORING MATTER, INK COMPOSITION, RECORDING METHOD, AND COLORED OBJECT NIPPON KAYAKU KK (JP) 2017-09-06 EP disclosed
EP-2463345-B1 Ink composition, recording method using the same and recorded material SEIKO EPSON CORP (JP) 2017-01-18 EP disclosed
US-20160160065-A1 INK COMPOSITION, INK JET RECORDING METHOD USING SAME, AND COLORED MATERIAL NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2016-06-09 US disclosed
EP-3015516-A1 INK COMPOSITION, INK JET RECORDING METHOD USING SAME, AND COLORED MATERIAL Nippon Kayaku Kabushiki Kaisha (JP) 2016-05-04 EP disclosed
EP-2420538-B1 PORPHYRAZINE DYE, INK COMPOSITION CONTAINING SAME, AND COLORED BODY NIPPON KAYAKU KK (JP) 2015-04-22 EP disclosed
US-8876273-B2 Ink composition, ink jet recording method using the same and recorded material SEIKO EPSON CORPORATION (JP) 2014-11-04 US disclosed
US-8857965-B2 Ink compostion, recording method using the same and recorded material SEIKO EPSON CORPORATION (JP) 2014-10-14 US disclosed
US-8790458-B2 Ink set and droplet ejection apparatus using the ink set SEIKO EPSON CORPORATION (JP) 2014-07-29 US disclosed
US-8668321-B2 Ink jet recording method and ink jet recording apparatus CANON KABUSHIKI KAISHA (JP) 2014-03-11 US disclosed
US-7585361-B2 Porphyrazine coloring matter, ink, ink set and colored product NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-09-08 US disclosed
US-7566362-B2 Ink, ink jet recording method, ink cartridge, recording unit and ink jet recording apparatus CANON KABUSHIKI KAISHA (JP) 2009-07-28 US disclosed
US-20090151599-A1 Porphyrazine Coloring Matter, Ink, Ink Set and Colored Product NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-06-18 US disclosed
EP-2028239-A1 Ink, ink jet recording method, ink cartridge, recording unit and ink jet recording apparatus CANON KABUSHIKI KAISHA (JP) 2009-02-25 EP disclosed
US-20090047430-A1 INK, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT AND INK JET RECORDING APPARATUS CANON KABUSHIKI KAISHA (JP) 2009-02-19 US disclosed
US-20090029120-A1 Novel Porphyrazine Coloring Matter, Ink, Ink Set and Colored Article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-01-29 US disclosed
EP-2017309-A1 PORPHYRAZINE DYE, INK, INK SET, AND COLORED MATTER Nippon Kayaku Kabushiki Kaisha (JP) 2009-01-21 EP disclosed
US-20080274286-A1 INK, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT, AND INK JET RECORDING APPARATUS CANON KABUSHIKI KAISHA (JP) 2008-11-06 US disclosed
EP-1988135-A1 Ink, ink jet recording method, ink cartridge, recording unit, and ink jet recording apparatus CANON KABUSHIKI KAISHA (JP) 2008-11-05 EP disclosed
EP-1985668-A1 NOVEL PORPHYRAZINE DYE, INK, INK SET, AND COLORED MATERIAL Nippon Kayaku Kabushiki Kaisha (JP) 2008-10-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029120-A1 Novel Porphyrazine Coloring Matter, Ink, Ink Set and Colored Article TDO2, IDO1, JAK1 CTDSP1 1505/4885ALDH1A1 3741/4885CYP1A2 892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.